tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Income Statement

Compare
0 Followers

Bafna Pharmaceuticals Limited Income Statement

Last quarter (Q3 2025), Bafna Pharmaceuticals Limited's total revenue was ₹331.88M, an increase of 16.68% from the same quarter last year. In Q3, Bafna Pharmaceuticals Limited's net income was ₹9.48M. See Bafna Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 1.46B₹ 1.52B₹ 1.15B₹ 851.40M₹ 712.18M
Gross Profit
₹ 168.77M₹ 452.15M₹ 387.56M₹ 336.00M₹ 89.83M
Operating Expenses
₹ 105.89M₹ 214.49M₹ 266.88M₹ 272.51M₹ 196.24M
Depreciation and Amortization
₹ 48.90M₹ 49.95M₹ 53.34M₹ 54.93M₹ 44.78M
EBITDA
₹ 117.73M₹ 146.34M₹ 189.88M₹ 112.34M₹ 103.94M
Operating Income
₹ 62.87M₹ 237.66M₹ 117.72M₹ 66.41M₹ 61.38M
Other Income/Expenses
₹ -21.35M₹ -164.18M₹ -1.56M₹ -14.25M₹ -3.11M
Pretax Income
₹ 41.52M₹ 73.48M₹ 116.16M₹ 52.16M₹ 58.27M
Net Income
₹ 41.52M₹ 73.48M₹ 113.38M₹ 52.16M₹ 58.27M
Per Share Metrics
Basic EPS
₹ 1.76₹ 3.11₹ 4.79₹ 2.21₹ 2.46
Diluted EPS
₹ 1.76₹ 3.11₹ 4.79₹ 2.21₹ 2.46
Weighted Average Shares Outstanding
0.00 23.63M 23.66M 23.66M 23.69M
Weighted Average Shares Outstanding (Diluted)
0.00 23.66M 23.66M 23.66M 23.69M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis